September 25, 2017 3:26 PM ET


Company Overview of Fabre-Kramer Pharmaceuticals, Inc.

Company Overview

Fabre-Kramer Pharmaceuticals, Inc. acquires, develops, and commercializes psychotropic drugs. It offers Travivo, a compound to treat major depressive disorder (MDD); FKB01MD, an antidepressant that down regulates 5HT2 receptors in animals; FKW00GA, a nonbenzodiazepine anxiolytic for social phobia; FKF02SC, an antipsychotic for schizophrenia; and FKK01PD, an postsynaptic D1 and D2 agonist for parkinson’s disease and erectile dysfunction; as well as other compounds for indications, including depression, anxiety, schizophrenia, bipolar disorder, social phobia, Parkinson's disease, and insomnia. The company provides products for therapeutic areas, such as psychiatry and neurology. It forms partn...

5847 San Felipe

Suite 2000

Houston, TX 77057

United States

Founded in 1992





Key Executives for Fabre-Kramer Pharmaceuticals, Inc.

Chief Executive Officer
Chief Financial Officer and Executive Vice President of Licensing & Business Development
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fabre-Kramer Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at